Text
1. The plaintiff's claims against the defendants are all dismissed.
2. The costs of lawsuit shall be borne by the Plaintiff.
Reasons
1. Basic facts
A. The Plaintiff entered into an insurance contract with the Defendants as the insured and beneficiary, and concluded the insurance contract as follows.
Serial Insurance Co., Ltd. (unit: : 10/10 (class 3 surgery) cancer hospitalization expenses of more than 10/10 (class 3 surgery) cancer hospitalization expenses of more than 5/100 (class 3 surgery) disease hospitalization expenses of more than 10/100 (class 3 surgery), 2 Samsung Life Insurance Co., Ltd., Ltd., 1,800 cancer diagnosis allowances of more than 3/1,00 cancer hospitalization allowances of more than 1,80 cancer hospitalization allowances of more than 3/40 (not less than 3/1,00), 3/40 of cancer hospitalization allowances of more than 1.2/1,00 without dividends of more than 3/40 (not less than 3/1,000) and 3/40 of cancer hospitalization allowances of more than 3 Samsung Life Insurance Co., Ltd., Ltd., Ltd., 199, more than 1.3/43/100 of cancer hospitalization surgery of more than 33/4.5 days (3/4.4 days of cancer surgery.
B. The contents of the terms and conditions of the insurance contract 1) Article 16(1), Article 21, attached Table 4, and Article 10 of the General Terms and Conditions of the Non-Distribution 3 Insurance Act contain the following contents. The definition of cancer: The diagnosis and confirmation of malicious species cancer, which exists in malicious cells and can be characterized by the scopical proliferation of malicious cells and its surrounding organization, must be conducted by a person with a professional doctor's license of scopic pathology or clinical pathology, and the diagnosis shall be based on the scopic opinion of the scopic pathology or blood test, and the term "wastes" shall be based on the scopic opinion of the scopic scopic scopic scopic scopic scopic scopic scopic scopic scopic scopic scopic scopic scopic scopic sc
2. Article 14 of the State Insurance Terms and Conditions for Preliminary Life C15 to C26 Non-Distribution 2 Cancer Insurance, and Article 3 of the State Insurance Terms and Conditions for Cancer Treatment of Women's Health Insurance.